NCPA Expresses Concerns Over Medicare Drug Price Negotiation Plan Rollout, Citing Potential Impact on Community Pharmacies

Ronna Hauser, PharmD, senior vice president of policy and pharmacy affairs at the National Community Pharmacists Association (NCPA), addressed the organization’s concerns regarding the rollout of the Medicare Drug Price Negotiation Plan. The association has specific reservations about the plan’s implementation process and potential impact on community pharmacies. Hauser outlined NCPA’s worries, focusing on potential challenges community pharmacies may face under the new negotiation plan. These challenges included navigating the complexities of the new system and maintaining their financial viability while adapting to altered reimbursement structures. She further elaborated on the association’s commitment to advocating for policies that support community pharmacies and ensure patient access to medications.

Newsflash | Powered by GeneOnline AI
Date: April 23, 2025

Author

Mark Chiang